$1.71 EPS Expected for Rockwell Automation (ROK); Harvard Bioscience (HBIO) Has 1.09 Sentiment

October 13, 2017 - By Dolores Ford

Harvard Bioscience, Inc. is a developer, maker and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The company has market cap of $130.63 million. The Company’s products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. It currently has negative earnings. The Company’s product range is organized into three commercial product families: Cell and Animal Physiology , Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA).

Analysts expect Rockwell Automation (NYSE:ROK) to report $1.71 EPS on November, 6.They anticipate $0.19 EPS change or 12.50% from last quarter’s $1.52 EPS. ROK’s profit would be $219.52 million giving it 27.23 P/E if the $1.71 EPS is correct. After having $1.76 EPS previously, Rockwell Automation’s analysts see -2.84% EPS growth. About 353,300 shares traded. Rockwell Automation (NYSE:ROK) has risen 42.76% since October 13, 2016 and is uptrending. It has outperformed by 26.06% the S&P500.

Among 25 analysts covering Rockwell Automation (NYSE:ROK), 4 have Buy rating, 3 Sell and 18 Hold. Therefore 16% are positive. Rockwell Automation had 50 analyst reports since September 9, 2015 according to SRatingsIntel. The stock of Rockwell Automation (NYSE:ROK) has “Underperform” rating given on Thursday, October 29 by Bank of America. The rating was downgraded by Bernstein on Thursday, January 28 to “Underperform”. The stock has “Hold” rating by Langenberg on Thursday, April 28. Robert W. Baird downgraded Rockwell Automation (NYSE:ROK) rating on Monday, October 5. Robert W. Baird has “Neutral” rating and $100 target. As per Thursday, July 27, the company rating was upgraded by JP Morgan. The company was upgraded on Monday, January 9 by Bank of America. The rating was maintained by Citigroup on Monday, October 9 with “Neutral”. The company was downgraded on Monday, October 5 by Barclays Capital. Bernstein upgraded Rockwell Automation (NYSE:ROK) on Friday, September 30 to “Mkt Perform” rating. The stock of Rockwell Automation (NYSE:ROK) has “Neutral” rating given on Wednesday, August 23 by Credit Suisse.

Investors sentiment increased to 1.26 in 2017 Q2. Its up 0.04, from 1.22 in 2017Q1. It increased, as 34 investors sold Rockwell Automation shares while 190 reduced holdings. 74 funds opened positions while 209 raised stakes. 87.06 million shares or 0.70% more from 86.45 million shares in 2017Q1 were reported. Primecap Ca holds 0.11% of its portfolio in Rockwell Automation (NYSE:ROK) for 810,710 shares. Trillium Asset Management Limited Liability accumulated 31,083 shares. Vanguard Gp Incorporated reported 8.77M shares. Next Financial Group Inc reported 910 shares stake. Blair William And Co Il has invested 0.01% of its portfolio in Rockwell Automation (NYSE:ROK). Amica Retiree Med invested in 1,010 shares or 0.13% of the stock. Bp Public Limited Liability Company reported 0.12% in Rockwell Automation (NYSE:ROK). 15,172 were accumulated by Amalgamated Bank. Qs Investors Ltd Liability Corporation has invested 0% of its portfolio in Rockwell Automation (NYSE:ROK). Twin Cap Mgmt invested 0.18% of its portfolio in Rockwell Automation (NYSE:ROK). Legal And General Gru Public Limited Liability Corporation holds 0.09% of its portfolio in Rockwell Automation (NYSE:ROK) for 689,526 shares. Park Oh accumulated 0.01% or 1,445 shares. Bridgecreek Invest Mgmt Ltd Liability has invested 0.78% of its portfolio in Rockwell Automation (NYSE:ROK). Utd Svcs Automobile Association holds 0.09% or 184,058 shares in its portfolio. British Columbia Mgmt Corporation stated it has 69,684 shares or 0.09% of all its holdings.

Since May 2, 2017, it had 0 insider purchases, and 14 insider sales for $19.34 million activity. Another trade for 4,000 shares valued at $634,827 was sold by Kulaszewicz Frank C. 3,000 shares valued at $475,635 were sold by Etzel Steven W. on Monday, May 15. 5,000 shares valued at $795,377 were sold by Champa Kenneth M on Wednesday, May 31. Another trade for 19,037 shares valued at $2.97 million was made by CRANDALL THEODORE D on Tuesday, May 2. 10,000 shares were sold by NOSBUSCH KEITH D, worth $1.56M on Friday, May 5. Another trade for 432 shares valued at $68,288 was made by MCCORMICK WILLIAM T JR/WI on Monday, May 15. Fooks Elik I sold $477,113 worth of stock or 3,000 shares.

Rockwell Automation, Inc. is a well-known provider of industrial automation power, control and information solutions for manufacturers. The company has market cap of $23.91 billion. The Firm operates through two divisions: Architecture & Software and Control Products & Solutions. It has a 30.02 P/E ratio. The Architecture & Software segment contains various hardware, software and communication components of the Company’s integrated control and information architecture capable of controlling the customer’s industrial processes and connecting with their manufacturing enterprise.

Since January 1, 0001, it had 4 buys, and 0 selling transactions for $74,561 activity.

Analysts await Harvard Bioscience, Inc. (NASDAQ:HBIO) to report earnings on October, 26. They expect $0.01 EPS, 0.00% or $0.00 from last year’s $0.01 per share. HBIO’s profit will be $348,347 for 93.75 P/E if the $0.01 EPS becomes a reality. After $0.01 actual EPS reported by Harvard Bioscience, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com